|1st July 2020||Peter Jerome||35,461||Grant/award etc.||$0.37||$13,120.57|
|1st July 2020||Chaim Davis||35,461||Grant/award etc.||$0.37||$13,120.57|
|1st July 2020||Jean Neff||35,461||Grant/award etc.||$0.37||$13,120.57|
|8th April 2020||Chaim Davis||7,751||Grant/award etc.||$0.21||$1,627.71|
|8th April 2020||Peter Jerome||7,751||Grant/award etc.||$0.21||$1,627.71|
|8th April 2020||Jean Neff||7,751||Grant/award etc.||$0.21||$1,627.71|
|2nd March 2020||Chaim Davis||528,571||Open or private purchase||$0.07||$36,999.97|
|10th October 2019||Chaim Davis||37,398||Grant/award etc.||$0.09||$3,365.82|
|10th October 2019||Jean Neff||23,014||Grant/award etc.||$0.09||$2,071.26|
|10th October 2019||Peter Jerome||37,398||Grant/award etc.||$0.09||$3,365.82|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 1/10.
American Bio Medica Corp. engages in the manufacture and sale of immunoassay tests. It offers products relating to urinalysis, oral fluids, alcohol testing, hair testing, pregnancy testing, contract manufacturing, and lab partners. The company was founded by Stan Cipkowski and Edmund M. Jaskiewicz in 1986.